Elasomeran/tozinameranGross haematuria and fever: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2037卷 / 1期

关键词：

D O I：

10.1007/s40278-024-71858-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：165 / 165

相关论文

共 50 条

[1] Cyclophosphamide/elasomeran/tozinameranGross haematuria and lack of efficacy: 10 case reports
Reactions Weekly, 2023, 1939 (1) : 157 - 157
[2] Elasomeran/TozinameranGross haematuria and IgA nephropathy
Reactions Weekly, 2024, 2008 (1) : 141 - 141
[3] Antiplatelets/elasomeran/rivaroxabanGross haematuria and epistaxis : 2 case reports
Reactions Weekly, 2023, 1956 (1) : 70 - 70
[4] Elasomeran/tozinameranMyocarditis : 3 case reports
Reactions Weekly, 2024, 2018 (1) : 190 - 190
[5] Elasomeran/tozinameranTreatment failure: 3 case reports
Reactions Weekly, 2022, 1920 (1) : 210 - 210
[6] Elasomeran/tozinameranVarious toxicities: 3 case reports
Reactions Weekly, 2023, 1948 (1) : 192 - 192
[7] Elasomeran/tozinameranNeuralgic amyotrophy: 3 case reports
Reactions Weekly, 2023, 1939 (1) : 194 - 194
[8] HeparinHaematoma and haematuria: 3 case reports
Reactions Weekly, 2016, 1613 (1) : 145 - 145
[9] Elasomeran/tozinameranVaccine failure: 3 case reports
Reactions Weekly, 2023, 1960 (1) : 184 - 184
[10] HeparinGross haematuria: 3 case reports
Reactions Weekly, 2020, 1814 (1) : 161 - 161

← 1 2 3 4 5 →